Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$377K Buy
1,041
+19
+2% +$6.5K 0.11% 96
2026
Q1
$360K Sell
1,022
-306
-23% -$109K 0.12% 87
2025
Q4
$435K Buy
+1,328
New +$421K 0.14% 77
2024
Q4
Sell
-104
Closed -$33.5K 137
2024
Q3
$33.5K Buy
+104
New +$34K 0.01% 346
2024
Q1
Sell
-104
Closed -$30K 118
2023
Q4
$30K Buy
+104
New +$28.3K 0.01% 340
2021
Q1
Sell
-704
Closed -$162K 76
2020
Q4
$162K Buy
704
+100
+17% +$23.1K 0.13% 66
2020
Q3
$154K Buy
+604
New +$150K 0.15% 57

Other funds holding AMGN

Planned Solutions's AMGN Position: Q2 2026 in Review

Planned Solutions increased its Amgen (AMGN) stake by 1.9% in Q2 2026, buying an estimated $6.5K and bringing the position to 1,041 shares worth $377K. The position accounts for 0.11% of the portfolio, ranked #96.

Planned Solutions first reported a position in AMGN in Q3 2020 and has held it in 7 quarters since. The position peaked at $435K in Q4 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Planned Solutions held 1,041 shares of Amgen worth $377K as of Q2 2026.
  • Planned Solutions bought 19 Amgen shares in Q2 2026, an estimated $6.5K.
  • Amgen made up 0.11% of Planned Solutions's portfolio in Q2 2026, its #96 holding.
  • Planned Solutions first reported a position in Amgen in Q3 2020 and has held it in 7 quarters since.
  • Planned Solutions's Amgen position peaked at $435K in Q4 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Planned Solutions's 13F filing for Q2 2026, filed 13 Jul 2026.